news 2 페이지

본문 바로가기
ENG
Home  >  PR  >  News
NEWS

검색

news 목록
NO. Title Date
117 Genematrix acquired official approval by ANVISA for COVID-19 detection kit 2020.10.13
116 Genematrix, selected as the “Self-sufficiency project for Essential vaccination” by the government 2020.10.08
115 Genematrix acquired approval by KFDAㆍCE for Multiplex detection kit for 9 types of respiratory infection viruses 2020.10.06
114 Genematrix acquired export permit for COVID-19 and Influenza, aiming at EUA 2020.09.29
113 Genematrix and UNICEF signed a Long-Term Agreement(LTA) for supply of COVID-19 detection kit 2020.09.29
112 Genematrix acquired FDA EUA for COVID-19 detection kit 2020.09.22
111 Gene Matrix, operating profit of 3.9 billion won in the first half...turned a profit compared to the previous year 2020.08.14
110 Genematrix signed a contract to supply COVID-19 detection kit for 500 Million won 2020.06.08
109 Genematrix signed a contract to supply COVID-19 detection kit for 500 Million won 2020.06.05
108 Genematrix applied for a new technology patent based on T-cell immunotherapy 2020.06.02
107 Genematrix acquired EUA for COVID-19 detection kit 2020.05.15
106 MSS(Ministry of SMEs and Startups) holds a meeting with companies with R&D achievements in quarantine and zero-contact 2020.05.04
105 Genematrix's detection kit for 10 respiratory viruses, approved by KFDA 2020.04.29
104 Genematrix signed a 500 million won contract with an Italian local agent 2020.04.16
103 Genematrix signed a 400 million won supply contract to export COVID-19 detection kit to Italy 2020.04.07

회원로그인

회원가입